AEGEA Medical is developing technology that utilizes convective water vapor to treat menorrhagia. The AEGEA Vapor System delivers controlled, low-pressure natural water vapor to the uterine cavity to efficiently ablate the inner lining of the uterus. AEGEA's technology enables delivery of adaptive water vapor in a simple office-based procedure designed to take only minutes to complete and to provide a reduction or cessation of uterine bleeding and improved quality of life.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/04/15 | $36,000,000 | Series C |
BioMed Ventures Delphi Ventures Solas Bioventures | undisclosed |
